A Multi-center, Randomized, Single-dose, Double-blind, 4-way Cross-over Study to Evaluate Tolerability Following Treatment With Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma.
Phase of Trial: Phase I
Latest Information Update: 26 Aug 2010
At a glance
- Drugs Indacaterol (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors Novartis
- 10 Aug 2008 The expected completion date has changed from Apr 2008 to Sep 2008 as reported by ClinicalTrials.gov.
- 21 Mar 2008 New trial record.